| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |